B Hickey - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

B Hickey

Showing results (81-90 of 83) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 83 results.

Bioorganic & Medicinal Chemistry Letters|November 23, 2007

The discovery of GSK221149A: a potent and selective oxytocin antagonistJohn Liddle, Michael J Allen, Alan D Borthwick, et al.

Bioorganic & Medicinal Chemistry Letters|August 17, 2002

The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in manJosie A Blackie, Jackie C Bloomer, Murray J B Brown, et al.

Journal of the American Society of Nephrology : JASN|March 5, 2016

Urinary Soluble CD163 in Active Renal VasculitisVincent P O'Reilly, Limy Wong, Claire Kennedy, et al.

Pageof 9

Search research articles

Showing results (81-90 of 83) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 83 results.

Bioorganic & Medicinal Chemistry Letters|November 23, 2007

The discovery of GSK221149A: a potent and selective oxytocin antagonistJohn Liddle, Michael J Allen, Alan D Borthwick, et al.

Bioorganic & Medicinal Chemistry Letters|August 17, 2002

The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in manJosie A Blackie, Jackie C Bloomer, Murray J B Brown, et al.

Journal of the American Society of Nephrology : JASN|March 5, 2016

Urinary Soluble CD163 in Active Renal VasculitisVincent P O'Reilly, Limy Wong, Claire Kennedy, et al.

Pageof 9